were calibrated weekly with a mixture of 100 ppm carbon monoxide in air.
Two successive readings were taken with the EC50 to check the possibility that asymptotic readings might not be reached after a single exhalation when sample capture is by diffusion.
Expired air carbon monoxide concentrations measured by EC50 and by COTracer monitors correlated closely with carboxyhaemoglobin concentration (r = 095 and 098, n = 75 (see figure) ), as did the Ecolyzer (r = 0 98, n = 75). The relationship with carboxyhaemoglobin concentrations (which ranged from 0-3% to 12%) was linear over this range; the slopes of the regression lines for the two instruments were identical and similar to the slope previously reported for the Ecolyzer. 4 The results show that, as an approximate guide, the percentage of carboxyhaemoglobin is given by dividing the expired air reading by 6 . The second reading on the EC50 was somewhat higher than the first (mean values 17 3 and 15 7 ppm; p < 0 001), confirming that diffusion sampling may not yield an asymptotic value with one exhalation.
Readings from the three expired air monitors were highly correlated with each other but, as has recently been pointed out,6 such high correlations may be consistent with considerable variation between measurements on different instruments; for example, the "limits of agreement" between the EC50 and the COTracer were + 7 ppm.
Discussion
Our results indicate that the EC50 and COTracer carbon monoxide monitors give an acceptably accurate guide to carboxy-haemoglobin concentrations over the range of values encountered in smokers and non-smokers. Their performance is similar to that of the Ecolyzer, but is achieved at a fraction of the cost. A further advantage of these devices is that they are compact and battery operated. Little drift in calibration was observed during several weeks. Our data were gathered in subjects without appreciable impairment of lung function, but previous work has shown that expired air measurements are a valuable guide to carboxyhaemoglobin even in patients with emphysema. 4 Monitoring 
